106 related articles for article (PubMed ID: 21738112)
1. Pathophysiological premises to radiotracers for bone metastases.
Cuccurullo V; Cascini G; Rossi A; Tamburrini O; Rotondo A; Mansi L
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):353-73. PubMed ID: 21738112
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of skeletal tumors using 113mIn-indifor].
Mechev DS; Siniuta BF
Med Radiol (Mosk); 1988 Jun; 33(6):22-7. PubMed ID: 2838715
[TBL] [Abstract][Full Text] [Related]
3. Bone metastases radiopharmaceuticals: an overview.
Cuccurullo V; Cascini GL; Tamburrini O; Rotondo A; Mansi L
Curr Radiopharm; 2013 Mar; 6(1):41-7. PubMed ID: 23470032
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear oncology update].
Maublant J; Resche I; Giammarile F; Corone C; Artus JC
Bull Cancer; 1999 Jan; 86(1):57-64. PubMed ID: 10029706
[No Abstract] [Full Text] [Related]
5. [A bone scintigraphy with abdominopelvic uptake of ⁹⁹mTc-diphosphonate].
Achury CA; Domènech A; Geraldo L; Duch J; Carrió I; Flotats A
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):326-7. PubMed ID: 24746900
[No Abstract] [Full Text] [Related]
6. Radionuclide bone imaging.
Bassett LW; Gold RH; Webber MM
Radiol Clin North Am; 1981 Dec; 19(4):675-702. PubMed ID: 7034044
[TBL] [Abstract][Full Text] [Related]
7. Normal technetium 99m diphosphonate bone scintigraphy in skeletal metastases from hepatocellular carcinoma.
Maillefert JF; Tebib J; Quipourt V; Brunotte F; Michiels C; Hillon P; Tavernier C
J Hepatol; 1994 Oct; 21(4):684. PubMed ID: 7814817
[No Abstract] [Full Text] [Related]
8. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
[TBL] [Abstract][Full Text] [Related]
9. 177Lu-EDTMP: a potential therapeutic bone agent.
Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N
Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664
[TBL] [Abstract][Full Text] [Related]
10. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
Ghiron J; Volkert WA; Garlich J; Holmes RA
Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
[TBL] [Abstract][Full Text] [Related]
11. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
Brenner W; Kampen WU; Kampen AM; Henze E
J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
[TBL] [Abstract][Full Text] [Related]
12. Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.
Storto G; Gallicchio R; Pellegrino T; Nardelli A; De Luca S; Capacchione D; Sirignano C; Pace L
Nucl Med Biol; 2013 May; 40(4):518-23. PubMed ID: 23522973
[TBL] [Abstract][Full Text] [Related]
13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
Yang JS
Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
[No Abstract] [Full Text] [Related]
15. Extraskeletal localization of 99mTc-labeled bone-seeking tracers in bone scintigraphy.
Arend SM; Pauwels EK; Arndt JW; Meinders AE
Neth J Med; 1994 Oct; 45(4):177-91. PubMed ID: 7808581
[TBL] [Abstract][Full Text] [Related]
16. [The measurement of 153Sm-EDTMP bone uptake rate and its relationship with therapeutic effect].
Li L; Liang Z; Deng H; Li Y; Zhang X; Yang X
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):446-8. PubMed ID: 12536590
[TBL] [Abstract][Full Text] [Related]
17. Imaging of bone metastases with 99m Tc-Sn-EHDP (diphosphonate), 18 F, and skeletal radiography. A comparison of sensitivity.
Silberstein EB; Saenger EL; Tofe AJ; Alexander GW; Park HM
Radiology; 1973 Jun; 107(3):551-5. PubMed ID: 4633984
[No Abstract] [Full Text] [Related]
18. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
19. [X-ray and scintigraphic diagnosis of thyroid cancer metastatic to bone].
Babushkin VV; Zvekotkina LS; Naumenko AZ
Med Radiol (Mosk); 1989 May; 34(5):20-5. PubMed ID: 2498605
[TBL] [Abstract][Full Text] [Related]
20. Role of mineralisation in the uptake of bone-seeking tracers.
Leitha T
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1369. PubMed ID: 16830119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
